Target
Serine/threonine-protein kinase 24
Ligand
BDBM451750
Substrate
n/a
Meas. Tech.
Biochemical Assay
IC50
>1000±n/a nM
Citation
 Gray, NSBuhrlage, SAnderson, KCottini, FTonon, G STK4 inhibitors for treatment of hematologic malignancies US Patent  US10710978 Publication Date 7/14/2020 
Target
Name:
Serine/threonine-protein kinase 24
Synonyms:
MST3 | STK24 | STK24_HUMAN | STK3
Type:
PROTEIN
Mol. Mass.:
49300.82
Organism:
Homo sapiens (Human)
Description:
ChEMBL_774397
Residue:
443
Sequence:
MDSRAQLWGLALNKRRATLPHPGGSTNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWKAEQSHDDSSSEDSDAETDGQASGGSDSGDWIFTIREKDPKNLENGALQPSDLDRNKMKDIPKRPFSQCLSTIISPLFAELKEKSQACGGNLGSIEELRGAIYLAEEACPGISDTMVAQLVQRLQRYSLSGGGTSSH
  
Inhibitor
Name:
BDBM451750
Synonyms:
6-(2-amino-5-(2-methoxy-4- (thiazol-2-yl)phenyl)pyridin- 3-yl)-3,4-dihydroisoquinolin- 1(2H)-one | US10710978, Compound I-60
Type:
Small organic molecule
Emp. Form.:
C24H20N4O2S
Mol. Mass.:
428.506
SMILES:
COc1cc(ccc1-c1cnc(N)c(c1)-c1ccc2C(=O)NCCc2c1)-c1nccs1
Structure:
Search PDB for entries with ligand similarity: